Risks

Weak interest coverage and very high net debt to EBITDA versus specialty chemical peers increase refinancing sensitivity if titanium dioxide pricing stays soft, pressuring equity value.

A long cash conversion cycle driven by elevated inventory days versus peers ties up working capital, limiting flexibility to absorb demand swings or margin compression.

High leverage relative to peers amplifies downside from cyclical end-market weakness, so any volume shortfall or price decline transmits more quickly into earnings deterioration.

Opportunities

If TiO2 pricing stabilizes, TROX’s operating leverage can lift earnings faster than less leveraged peers, because fixed-cost absorption improves sharply with incremental volume.

A current ratio above 2.5 provides more near-term liquidity than many peers, supporting working-capital management while the market remains volatile.

Overall Score

TROX’s forward positioning is constrained by extreme leverage and weak interest coverage versus peers, while any recovery in TiO2 pricing offers only limited near-term upside.